Kwangdong Healthbio Co., Ltd. (XKON:086220)
South Korea
· Delayed Price · Currency is KRW 1,340.00
-39.00 (-2.83%)
At close: Apr 28, 2026
Kwangdong Healthbio Revenue
In the year 2014, Kwangdong Healthbio had annual revenue of 38.10B KRW with 19.85% growth.
Revenue
38.10B
Revenue Growth
-2.50%
P/S Ratio
0.49
Revenue / Employee
470.33M
Employees
81
Market Cap
18.77B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2014 | 38.10B | 6.31B | 19.85% |
| Dec 31, 2013 | 31.79B | -4.07B | -11.35% |
| Dec 31, 2012 | 35.86B | 6.04B | 20.27% |
| Dec 31, 2011 | 29.81B | -17.09B | -36.44% |
| Dec 31, 2010 | 46.91B | 527.66M | 1.14% |
| Dec 31, 2009 | Pro | Pro | Pro |
| Dec 31, 2008 | Pro | Pro | Pro |
| Dec 31, 2007 | Pro | Pro | Pro |
| Dec 31, 2006 | Pro | Pro | Pro |
| Dec 31, 2005 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Future Medicine | 1.00B |
| Union Korea Pharm | 36.38B |
| CXI Healthcare Technology Group | 54.16B |
| WooGene B&G | 54.76B |
| BIFIDO | 19.68B |
| Hurum | 99.01B |
| Bioten | 10.71B |
| Pharmsville | 12.73B |